Skip to main content

Dermatological side effects and complications of continuous subcutaneous insulin infusion in preschool-age and school-age children

Buy Article:

$43.00 plus tax (Refund Policy)

Schober E, Rami B. Dermatological side effects and complications of continuous subcutaneous insulin infusion in preschool-age and school-age children.

Pediatric Diabetes 2009: 10: 198–201. Objective: 

The objective of this study was to evaluate whether very young children develop more dermatological complications during insulin pump treatment compared with school children. Study design: 

Cross-sectional study in 78 consecutive children using insulin pump treatment >4 months. Results: 

Children in group A [n = 40, 28 males (M) and 12 females (F)] were 2.3 ± 1.3 yr (±SD) and those in group B (n = 38, 13 M and 25 F) were 11.0 ± 2.9 yr old at the start of continuous subcutaneous insulin infusion (CSII). The mean duration of CSII was similar in both groups (23.6 ± 16.5 months in group A and 21.8 ± 16.1 in group B). The most common dermatological complications were scars <3 mm (50% in group A vs. 71% in group B, p < 0.05) and lipohypertrophic areas at the insertion sites (45% in group vs. 47% in group B). Local abscesses and blisters were rare findings in both groups (7.5–12%), none leading to interruption or stop of CSII. Conclusions: 

Dermatological side effects during CSII are not more frequent or severe in very young diabetic children compared with diabetic children in school age.
No References
No Citations
No Supplementary Data
No Data/Media
No Metrics

Keywords: CSII; T1DM children; children; dermatological side effects

Document Type: Research Article

Affiliations: Department of Pediatric and Adolescent Medicine, Medical University Vienna, Vienna, Austria

Publication date: 2009-05-01

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more